IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 98 filers reported holding IDEAYA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,330 | +35.3% | 86,326 | +17.8% | 0.00% | 0.0% |
| Q2 2023 | $1,722 | +101.4% | 73,277 | +17.7% | 0.00% | – |
| Q1 2023 | $855 | -50.1% | 62,257 | -34.0% | 0.00% | -100.0% |
| Q4 2022 | $1,715 | -99.8% | 94,343 | +33.6% | 0.00% | 0.0% |
| Q3 2022 | $1,053,000 | +3090.9% | 70,608 | +2886.8% | 0.00% | – |
| Q2 2022 | $33,000 | -45.9% | 2,364 | -56.6% | 0.00% | – |
| Q1 2022 | $61,000 | -96.8% | 5,442 | -93.2% | 0.00% | – |
| Q4 2021 | $1,880,000 | +441.8% | 79,520 | +485.3% | 0.00% | – |
| Q3 2021 | $347,000 | +37.7% | 13,587 | +12.8% | 0.00% | – |
| Q2 2021 | $252,000 | -27.6% | 12,047 | -18.9% | 0.00% | – |
| Q1 2021 | $348,000 | +376.7% | 14,856 | +183.5% | 0.00% | – |
| Q4 2020 | $73,000 | -19.8% | 5,240 | -28.0% | 0.00% | – |
| Q3 2020 | $91,000 | -3.2% | 7,276 | +9.8% | 0.00% | – |
| Q2 2020 | $94,000 | – | 6,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |